• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

良性前列腺梗阻的微创外科治疗的现代进展。

Modern advancements in minimally invasive surgical treatments for benign prostatic obstruction.

作者信息

Pascoe John, Fontaine Christina, Hashim Hashim

机构信息

Specialist Registrar in Urology, University Hospitals Plymouth, Derriford Rd, Devon PL6 8DH, UK.

Specialist Registrar in Urology, University Hospitals Plymouth, Devon, UK.

出版信息

Ther Adv Urol. 2021 Jul 16;13:17562872211030832. doi: 10.1177/17562872211030832. eCollection 2021 Jan-Dec.

DOI:10.1177/17562872211030832
PMID:34349840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8287272/
Abstract

A wide variety of minimally invasive surgical techniques are now being offered for treating voiding lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO). These options offer an alternative to both medical therapy and traditional surgical options. Minimally invasive surgical treatments in LUTS/BPO boast both day case and local anaesthetic options, with a potentially reduced side effect profile compared to traditional surgical interventions matching the needs for a range of patients. We provide a narrative review of minimally invasive surgical treatments available for BPO in terms of the technology, efficacy, safety, institutional recommendations, cost and potential future developments.

摘要

目前，有各种各样的微创手术技术可用于治疗继发于良性前列腺梗阻（BPO）的下尿路排尿症状（LUTS）。这些选择为药物治疗和传统手术选择提供了替代方案。LUTS/BPO的微创手术治疗兼具日间手术和局部麻醉选择，与传统手术干预相比，副作用可能更少，满足了一系列患者的需求。我们从技术、疗效、安全性、机构建议、成本和潜在的未来发展等方面，对可用于BPO的微创手术治疗进行了叙述性综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/91f9cbe40e9f/10.1177_17562872211030832-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/509f619ae428/10.1177_17562872211030832-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/5a1c9d839360/10.1177_17562872211030832-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/8ed10af1aedc/10.1177_17562872211030832-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/bf23da105757/10.1177_17562872211030832-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/515835121bdf/10.1177_17562872211030832-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/3d42d8206032/10.1177_17562872211030832-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/b206fb8b9552/10.1177_17562872211030832-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/91f9cbe40e9f/10.1177_17562872211030832-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/509f619ae428/10.1177_17562872211030832-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/5a1c9d839360/10.1177_17562872211030832-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/8ed10af1aedc/10.1177_17562872211030832-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/bf23da105757/10.1177_17562872211030832-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/515835121bdf/10.1177_17562872211030832-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/3d42d8206032/10.1177_17562872211030832-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/b206fb8b9552/10.1177_17562872211030832-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c89/8287272/91f9cbe40e9f/10.1177_17562872211030832-fig8.jpg

相似文献

1
Modern advancements in minimally invasive surgical treatments for benign prostatic obstruction.良性前列腺梗阻的微创外科治疗的现代进展。
Ther Adv Urol. 2021 Jul 16;13:17562872211030832. doi: 10.1177/17562872211030832. eCollection 2021 Jan-Dec.
2
Pharmacological and interventional treatment of benign prostatic obstruction: An evidence-based comparative review.良性前列腺梗阻的药物及介入治疗：一项基于证据的比较性综述
BJUI Compass. 2021 Feb 3;2(4):238-259. doi: 10.1002/bco2.74. eCollection 2021 Jul.
3
[Minimally invasive treatment of benign prostatic hyperplasia : The German S2e guideline 2023-part 4].[良性前列腺增生的微创治疗：2023年德国S2e指南 - 第4部分]
Urologie. 2024 Jan;63(1):58-66. doi: 10.1007/s00120-023-02249-4. Epub 2024 Jan 9.
4
Minimally Invasive Therapies for Benign Prostatic Obstruction: A Review of Currently Available Techniques Including Prostatic Artery Embolization, Water Vapor Thermal Therapy, Prostatic Urethral Lift, Temporary Implantable Nitinol Device and Aquablation.良性前列腺梗阻的微创治疗：对当前可用技术的综述，包括前列腺动脉栓塞、水蒸气热疗、前列腺尿道悬吊、临时可植入镍钛诺装置和水消融。
Cardiovasc Intervent Radiol. 2022 Apr;45(4):415-424. doi: 10.1007/s00270-021-03052-4. Epub 2022 Jan 18.
5
Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms.男性下尿路症状的新兴微创治疗选择。
Eur Urol. 2017 Dec;72(6):986-997. doi: 10.1016/j.eururo.2017.07.005. Epub 2017 Jul 19.
6
Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.男性良性前列腺增生症下尿路症状的微创治疗：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jul 15;7(7):CD013656. doi: 10.1002/14651858.CD013656.pub2.
7
The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.新型微创治疗良性前列腺增生相关下尿路症状的作用。
BJU Int. 2020 Sep;126(3):317-326. doi: 10.1111/bju.15154. Epub 2020 Aug 3.
8
New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes.良性前列腺增生的新型超微创手术治疗：比较结果的系统评价与分析
Eur Urol Open Sci. 2021 Sep 22;33:28-41. doi: 10.1016/j.euros.2021.08.009. eCollection 2021 Nov.
9
[Surgical treatment of benign prostatic obstruction (BPO) in patients under anticoagulation: a review of the bleeding risks of established techniques].抗凝治疗患者良性前列腺梗阻（BPO）的外科治疗：现有技术的出血风险综述
Urologe A. 2020 Oct;59(10):1187-1194. doi: 10.1007/s00120-020-01319-1.
10
Beyond medications: office-based procedures for benign prostatic obstruction.超越药物治疗：良性前列腺梗阻的基于诊室的治疗方法。
World J Urol. 2019 Jun;37(6):1023-1027. doi: 10.1007/s00345-019-02720-y. Epub 2019 Apr 29.

引用本文的文献

1
A Comparative Study on the Clinical Outcomes of Bipolar Radiofrequency Thermotherapy Versus Transurethral Resection of the Prostate in Storage Symptoms Associated With Benign Prostatic Obstruction.双极射频热疗与经尿道前列腺切除术治疗良性前列腺梗阻所致储尿期症状的临床疗效比较研究
Int Neurourol J. 2024 Dec;28(4):285-293. doi: 10.5213/inj.2346184.092. Epub 2024 Dec 31.
2
Awareness and compliance of urologists in the Middle East with minimally invasive surgical devices for the management of benign prostate hyperplasia.中东地区泌尿外科医生对用于治疗良性前列腺增生的微创外科设备的认知与依从性。
Urol Ann. 2024 Apr-Jun;16(2):175-183. doi: 10.4103/ua.ua_106_23. Epub 2024 Apr 18.
3

本文引用的文献

1
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update.UroLift 治疗良性前列腺增生症下尿路症状：NICE 医疗技术指导更新。
Appl Health Econ Health Policy. 2022 Sep;20(5):669-680. doi: 10.1007/s40258-022-00735-y. Epub 2022 Jul 18.
2
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm and 80-150-cm Prostates.水对水II 2年更新：比较30 - 80厘米和80 - 150厘米前列腺良性前列腺增生的水消融治疗
Eur Urol Open Sci. 2021 Jan 31;25:21-28. doi: 10.1016/j.euros.2021.01.004. eCollection 2021 Mar.
3
Comprehensive Review on Current Controversies and Debate in Prostate Artery Embolization.
前列腺动脉栓塞术当前争议与辩论的综合综述
Turk J Urol. 2022 May;48(3):166-173. doi: 10.5152/tud.2022.21337.
The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial.
用于治疗良性前列腺增生继发下尿路症状的iTind临时植入镍钛诺装置：一项多中心、随机、对照试验。
Urology. 2021 Jul;153:270-276. doi: 10.1016/j.urology.2020.12.022. Epub 2020 Dec 26.
4
Efficacy and Safety of Surgery for Benign Prostatic Obstruction in Patients with Preoperative Urinary Catheter.术前留置导尿管的良性前列腺梗阻患者的手术疗效和安全性。
J Endourol. 2021 Jan;35(1):102-108. doi: 10.1089/end.2020.0704. Epub 2020 Sep 23.
5
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2020.《良性前列腺增生所致下尿路症状的外科治疗管理：2020 年 AUA 指南修订版》
J Urol. 2020 Oct;204(4):799-804. doi: 10.1097/JU.0000000000001298. Epub 2020 Jul 23.
6
iTIND: the second-generation temporary implantable nitinol device for minimally invasive treatment of benign prostatic hyperplasia.iTIND：用于微创治疗良性前列腺增生的第二代临时植入式镍钛诺装置。
Ther Adv Urol. 2020 Jun 25;12:1756287220934355. doi: 10.1177/1756287220934355. eCollection 2020 Jan-Dec.
7
Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial.钬激光经尿道前列腺剜除术与经尿道前列腺切除术治疗下尿路症状或尿潴留男性患者的效果比较（UNBLOCS）：一项随机对照试验。
Lancet. 2020 Jul 4;396(10243):50-61. doi: 10.1016/S0140-6736(20)30537-7.
8
Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.随机比较前列腺动脉栓塞术与经尿道前列腺切除术治疗良性前列腺增生。
J Vasc Interv Radiol. 2020 Jun;31(6):882-890. doi: 10.1016/j.jvir.2019.12.810. Epub 2020 Apr 2.
9
Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia.水蒸气热疗缓解良性前列腺增生所致的导管相关尿潴留。
Prostate Cancer Prostatic Dis. 2020 Jun;23(2):303-308. doi: 10.1038/s41391-019-0187-5. Epub 2019 Nov 18.
10
NICE Guidance - Transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia.英国国家卫生与临床优化研究所指南——经尿道水刀消融术治疗良性前列腺增生引起的下尿路症状
BJU Int. 2019 Sep;124(3):368-369. doi: 10.1111/bju.14863.